Physical training regulates mitochondrial parameters and neuroinflammatory mechanisms in an experimental model of Parkinson's disease

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Tuon, Talita ^a   Souza, Priscila S ^a   Santos, Marcela F ^a   Pereira, Fernanda T ^a   Pedroso, Giulia S ^a   Luciano, Thais F ^a   De Souza, Claudio T ^a   Dutra, Rafael C ^b   Silveira, Paulo C L ^a   Pinho, Ricardo A ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; AMINO ACIDS; AMPHIBIOUS VEHICLES; DISEASES; GLYCOPROTEINS; MAMMALS; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; SPORTING GOODS; VEHICLES;

DIFFERENT PROTOCOLS; EXPERIMENTAL GROUPS; EXPERIMENTAL MODELING; MITOCHONDRIAL FUNCTION; NUCLEAR FACTOR KAPPAB; TRANSFORMING GROWTH FACTORS; TUMOR NECROSIS FACTORS; TYROSINE HYDROXYLASE;

EXERCISE EQUIPMENT;

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; NITRIC OXIDE; OXIDOPAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SIRTUIN 1; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERVICAL SPINE DISLOCATION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; HIPPOCAMPUS; MALE; MITOCHONDRION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; RESISTANCE TRAINING; TREADMILL EXERCISE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; THEORETICAL MODEL;

ANIMALS; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MODELS, THEORETICAL; MOTOR ACTIVITY; PARKINSON DISEASE;

EID: 84942279346     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/261809     Document Type: Article

References (58)

1. S. Fahn and D. Sulzer, "Neurodegeneration and neuroprotection in Parkinson disease, " NeuroRx, vol. 1, no. 1, pp. 139-154, 2004.
2. L. M. de Lau and M. M. Breteler, "Epidemiology of Parkinsons disease, " The Lancet Neurology, vol. 5, no. 6, pp. 525-535, 2006.
3. W. Dauer and S. Przedborski, "Parkinsons disease:mechanisms and models, " Neuron, vol. 39, no. 6, pp. 889-909, 2003.
4. M. E. Emborg, "Evaluation of animal models of Parkinsons disease for neuroprotective strategies, " Journal of Neuroscience Methods, vol. 139, no. 2, pp. 121-143, 2004.
5. M. Varcin, E. Bentea, Y. Michotte, and S. Sarre, "Oxidative stress in genetic mouse models of Parkinsons disease, " Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 624925 25 pages, 2012.
6. P. M. Keeney, J. Xie, R. A. Capaldi, and J. P. Bennett Jr., "Parkinsons disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled, " Journal of Neuroscience, vol. 26, no. 19, pp. 5256-5264, 2006.
7. A. H. Schapira, "Mitochondrial disease, " The Lancet, vol. 368, no. 9529, pp. 70-82, 2006.
8. A. S. Aguiar Jr., T. Tuon, M. M. Albuquerque, et al., "Theexercise redox paradigm in the Downs syndrome: improvements in motor function and increases in blood oxidative status in young adults, " Journal of Neural Transmission, vol. 115, no. 12, pp. 1643-1650, 2008.
9. K. F. Winklhofer and C. Haass, "Mitochondrial dysfunction in Parkinsons disease, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1802, no. 1, pp. 29-44, 2010.
10. E. L. Lane, D. Soulet, L. Vercammen, M. A. Cenci, and P. Brundin, "Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinsons disease, " Neurobiology of Disease, vol. 32, no. 2, pp. 220-228, 2008.
11. L. C. Johnston, X. Su, K. Maguire-Zeiss, et al., "Human interleukin-gene transfer is protective in a ratmodel of Parkinsons disease, " MolecularTherapy, vol. 16, no. 8, pp. 1392-1399, 2008.
12. M. Sawada, K. Imamura, and T. Nagatsu, "Role of cytokines in inflammatory process in Parkinsons disease, " Journal of Neural Transmission-Supplement, vol. 70, pp. 373-381, 2006.
13. M. G. Tansey, T. C. Frank-Cannon, M. K. McCoy, et al., "Neuroinflammation in Parkinsons disease: is there sufficient evidence for mechanism-based interventional therapy?" Frontiers in Bioscience, vol. 13, no. 2, pp. 709-717, 2008.
14. B. Brodacki, J. Staszewski, B. Toczyłowska, et al., "Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism, " Neuroscience Letters, vol. 441, no. 2, pp. 158-162, 2008.
15. A. B. Knott and E. Bossy-Wetzel, "Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration, " Annals of the New York Academy of Sciences, vol. 1147, pp. 283-292, 2008.
16. L. C. M. Aleixo, S. R. F. Moreno, R. D. S. Freitas, H. Thomaz, S. D. Santos-Filho, andM. Bernardo-Filho, "Ginkgo biloba extract alters the binding of the sodium 123I iodide (Na 123I) on blood constituents, " Applied Radiation and Isotopes, vol. 70, no. 1, pp. 59-62, 2012.
17. D. C. Bolin, J. M. Donahue, M. L. Vickers, et al., "Equine abortion and premature birth associated with Cellulosimicrobium cellulans infection, " Journal of Veterinary Diagnostic Investigation, vol. 16, no. 4, pp. 333-336, 2004.
18. M. Decressac, B. Mattsson, and A. Bjorklund, "Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinsons disease, " Experimental Neurology, vol. 235, no. 1, pp. 306-315, 2012.
19. P. L. McGeer, S. Itagaki, H. Akiyama, and E. G. McGeer, "Rate of cell death in parkinsonism indicates active neuropathological process, " Annals of Neurology, vol. 24, no. 4, pp. 574-576, 1988.
20. C. Henchcliffe and F. M. Beal, "Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis, " Nature Clinical Practice Neurology, vol. 4, no. 11, pp. 600-609, 2008.
21. S. Hunot, N. Dugas, B. Faucheux, et al., "FcεRII/CD23 is expressed in Parkinsons disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells, " Journal of Neuroscience, vol. 19, no. 9, pp. 3440-3447, 1999.
22. E. C. Hirsch, S. Vyas, and S. Hunot, "Neuroinflammation in Parkinsons disease, " Parkinsonism and Related Disorders, vol. 18, supplement 1, pp. S210-S212, 2012.
23. M. E. Witte, J. J. G. Geurts, H. E. de Vries, P. van der Valk, and J. vanHorssen, "Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?" Mitochondrion, vol. 10, no. 5, pp. 411-418, 2010.
24. T. Tuon, S. S. Valvassori, J. Lopes-Borges, et al., "Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinsons disease, " Neuroscience, vol. 227, pp. 305-312, 2012.
25. T. Tuon, S. S. Valvassori, G. C. Dal Pont, et al., "Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinsons disease, " Brain Research Bulletin, vol. 108, pp. 106-112, 2014.
26. T. A. Hornberger Jr. and R. P. Farrar, "Physiological hypertrophy of the FHL muscle following 8 weeks of progressive resistance exercise in the rat, " Canadian Journal of Applied Physiology, vol. 29, pp. 16-31, 2014.
27. G. Paxinos and K. B. L. Franklin, TheMouse Brain in Stereotaxic Coordinates, Academic Press, New York, NY, USA, 2000.
28. M. M. Bradford, "A rapid and sensitive method for the quantitation ofmicrogram quantities of protein utilizing the principle of protein-dye binding, " Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
29. A. Cassina and R. Radi, "Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport, " Archives of Biochemistry and Biophysics, vol. 328, no. 2, pp. 309-316, 1996.
30. H. J. Chae, J. M. Park, G. Y. Lee, et al., "Yuk-Hap-Tang induces apoptosis by intervening Mn-SOD in human cervical carcinoma HeLa cells, " The American Journal of Chinese Medicine, vol. 32, no. 6, pp. 883-895, 2004.
31. U. K. Laemmli, "Cleavage of structural proteins during the assembly of the head of bacteriophage T4, " Nature, vol. 227, no. 5259, pp. 680-685, 1970.
32. L. Marais, D. J. Stein, andW. M. U. Daniels, "Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats, " Metabolic Brain Disease, vol. 24, no. 4, pp. 587-597, 2009.
33. T. Tuon, S. S. Valvassori, J. Lopes-Borges, et al., "Effects of moderate exercise on cigarette smoke exposure-induced hippocampal oxidative stress values and neurological behaviors in mice, " Neuroscience Letters, vol. 475, no. 1, pp. 16-19, 2010.
34. Z. Ke, S. P. Yip, L. Li, X.-X. Zheng, and K.-Y. Tong, "The effects of voluntary, involuntary, and forced exercises on brain-derived neurotrophic factor and motor function recovery: a rat brain ischemia model, " PLoS ONE, vol. 6, no. 2, Article ID e16643, 2011.
35. J. Haavik and K. Toska, "Tyrosine hydroxylase and Parkinsons disease, " Molecular Neurobiology, vol. 16, no. 3, pp. 285-309, 1998.
36. C. Da Cunha, E. C. Wietzikoski, M. M. Ferro, et al., "Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission, " Behavioural Brain Research, vol. 189, no. 2, pp. 364-372, 2008.
37. M.-C. Yoon, M.-S. Shin, T.-S. Kim, et al., "Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinsons rats, " Neuroscience Letters, vol. 423, no. 1, pp. 12-17, 2007.
38. F. Jin, Q. Wu, Y.-F. Lu, Q.-H. Gong, and J.-S. Shi, "Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinsons disease in rats, " European Journal of Pharmacology, vol. 600, no. 1-3, pp. 78-82, 2008.
39. N. Tajiri, T. Yasuhara, T. Shingo, et al., "Exercise exerts neuroprotective effects on Parkinsons disease model of rats, " Brain Research, vol. 1310, pp. 200-207, 2010.
40. A. S. Aguiar Jr., A. E. Speck, R. D. S. Prediger, F. Kapczinski, and R. A. Pinho, "Downhill training upregulates mice hippocampal and striatal brain-derived neurotrophic factor levels, " Journal of Neural Transmission, vol. 115, no. 9, pp. 1251-1255, 2008.
41. M. R. Ciucci, S. T. Ma, J. R. Kane, A. M. Ahrens, andT. Schallert, "Limb use and complex ultrasonic vocalization in a rat model of Parkinsons disease: deficit-targeted training, " Parkinsonismand Related Disorders, vol. 14, supplement 2, pp. S172-S175, 2008.
42. F. Blandini and M.-T. Armentero, "Animal models of Parkinsons disease, " FEBS Journal, vol. 279, no. 7, pp. 1156-1166, 2012.
43. G. Ramadori, C. E. Lee, A. L. Bookout, et al., "Brain SIRT1: anatomical distribution and regulation by energy availability, " Journal of Neuroscience, vol. 28, no. 40, pp. 9989-9996, 2008.
44. P. Wareski, A. Vaarmann, V. Choubey, et al., " PGC-1α and PGC-1β regulate mitochondrial density in neurons, " The Journal of Biological Chemistry, vol. 284, no. 32, pp. 21379-21385, 2009.
45. R. Acin-Perez, P. Fernandez-Silva, M. L. Peleato, A. Perez-Martos, and J. A. Enriquez, "Respiratory active mitochondrial supercomplexes, " Molecular Cell, vol. 32, no. 4, pp. 529-539, 2008.
46. W. Qin, T. Yang, L. Ho, et al., "Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction, " The Journal of Biological Chemistry, vol. 281, no. 31, pp. 21745-21754, 2006.
47. G. Donmez, A. Arun, C.-Y. Chung, P. J. Mclean, S. Lindquist, and L. Guarente, "SIRT1 protects against α-synuclein aggregation by activating molecular chaperones, " Journal of Neuroscience, vol. 32, no. 1, pp. 124-132, 2012.
48. H. Yang, W. Zhang, H. Pan, et al., "SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity, " PLoS ONE, vol. 7, Article ID e46364, 2012.
49. M. N. Sack and T. Finkel, "Mitochondrial metabolism, sirtuins, and aging, " Cold Spring Harbor Perspectives in Biology, vol. 1, pp. 4-12, 2012.
50. P. Garcia-Esparcia, F. Llorens, M. Carmona, and I. Ferrer, "Complex deregulation and expression of cytokines and mediators of the immune response in Parkinsons disease brain is region dependent, " Brain Pathology, vol. 24, no. 6, pp. 584-598, 2014.
51. J. B. Koprich, C. Reske-Nielsen, P. Mithal, and O. Isacson, "Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinsons disease, " Journal of Neuroinflammation, vol. 5, article 8, 2008.
52. C. F. Orr, D. B. Rowe, and G. M. Halliday, "An inflammatory review of Parkinsons disease, " Progress in Neurobiology, vol. 68, no. 5, pp. 325-340, 2002.
53. C. C. Chao, S. Hu, T. W. Molitor, E. G. Shaskan, and P. K. Peterson, "Activated microglia mediate neuronal cell injury via a nitric oxide mechanism, " Journal of Immunology, vol. 149, no. 8, pp. 2736-2741, 1992.
54. C. Barcia, C. M. Ros, V. Annese, et al., " IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinsons disease, " Cell Death & Disease, vol. 2, no. 4, article e142, 2011.
55. A. Członkowska, I. Kurkowska-Jastrzebska, A. Członkowski, D. Peter, and G. B. Stefano, "Immune processes in the pathogenesis of Parkinsons disease-a potential role for microglia and nitric oxide, "Medical ScienceMonitor, vol. 8, no. 8, pp. RA165-RA177, 2002.
56. N. Dugas, C. Lacroix, E. Kilchherr, J.-F. Delfraissy, and M. Tardieu, "Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis, " Cytokine, vol. 15, no. 2, pp. 96-107, 2001.
57. Y.-H. Sung, S.-C. Kim, H.-P. Hong, et al., "Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinsons disease mice, " Life Sciences, vol. 91, no. 25-26, pp. 1309-1316, 2012.
58. M. Al-Jarrah, H. Obaidat, Z. Bataineh, L. Walton, and A. Al-Khateeb, "Endurance exercise training protects against the upregulation of nitric oxide in the striatumofMPTP/probenecid mouse model of Parkinsons disease, " NeuroRehabilitation, vol. 32, no. 1, pp. 141-147, 2013.